Nureca Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Nureca şirketinin toplam hissedar öz sermayesi ₹1.9B ve toplam borcu ₹22.4M olup, bu da borç-öz sermaye oranını 1.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹2.1B ve ₹206.5M dir.

Anahtar bilgiler

1.2%

Borç/özkaynak oranı

₹22.41m

Borç

Faiz karşılama oranı	n/a
Nakit	₹282.86m
Eşitlik	₹1.94b
Toplam yükümlülükler	₹206.47m
Toplam varlıklar	₹2.15b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 543264 'nin kısa vadeli varlıkları ( ₹1.9B ) kısa vadeli yükümlülüklerini ( ₹165.0M ) aşıyor.

Uzun Vadeli Yükümlülükler: 543264 şirketinin kısa vadeli varlıkları ( ₹1.9B ) uzun vadeli yükümlülüklerini ( ₹41.5M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 543264 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 543264 'nin borç/öz sermaye oranı son 5 yılda 40% seviyesinden 1.2% seviyesine düştü.

Borç Kapsamı: 543264 'nin borcu işletme nakit akışı ( 284.8% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 543264 şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.

Nureca Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Nureca Limited Announces Board Appointments, Effective January 1, 2025

Second quarter 2025 earnings released: ₹0.48 loss per share (vs ₹2.90 profit in 2Q 2024)

Nureca Limited to Report Q2, 2025 Results on Oct 24, 2024

First quarter 2025 earnings released: EPS: ₹1.66 (vs ₹0.71 loss in 1Q 2024)

Nureca Limited to Report Q1, 2025 Results on Aug 05, 2024

Full year 2024 earnings released: ₹1.79 loss per share (vs ₹8.25 loss in FY 2023)

Nureca Limited, Annual General Meeting, Jul 18, 2024

Full year 2024 earnings released: ₹1.79 loss per share (vs ₹8.25 loss in FY 2023)

Nureca Limited to Report Q4, 2024 Results on May 15, 2024

Third quarter 2024 earnings released: EPS: ₹0.16 (vs ₹0.30 in 3Q 2023)

Nureca Limited to Report Nine Months, 2024 Results on Feb 07, 2024

Nureca Limited Announces Naresh Gupta Announces CFO Changes

Second quarter 2024 earnings released: EPS: ₹2.90 (vs ₹2.89 loss in 2Q 2023)

Nureca Limited to Report Q2, 2024 Results on Nov 04, 2023

New minor risk - Share price stability

Nureca Limited Announces Resignation of Nishant Garg as Chief Financial Officer, Effective December 6, 2023

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: ₹0.71 loss per share (vs ₹4.13 loss in 1Q 2023)

Nureca Limited to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings released: ₹8.25 loss per share (vs ₹44.96 profit in FY 2022)

Nureca Limited, Annual General Meeting, Jul 20, 2023

Nureca Limited to Report Q4, 2023 Results on May 23, 2023

Third quarter 2023 earnings released: EPS: ₹0.30 (vs ₹1.67 in 3Q 2022)

Nureca Limited to Report Q3, 2023 Results on Feb 03, 2023

Nureca Limited Announces Resignation of Nitin R. Bidikar as an Independent Director

Second quarter 2023 earnings released: ₹2.89 loss per share (vs ₹5.43 profit in 2Q 2022)

High number of new and inexperienced directors

Second quarter 2023 earnings released: ₹2.89 loss per share (vs ₹5.43 profit in 2Q 2022)

Nureca Limited to Report Q2, 2023 Results on Nov 11, 2022

Nureca Approves Interim Dividend for Financial Year 2021-22

First quarter 2023 earnings released: ₹4.13 loss per share (vs ₹36.20 profit in 1Q 2022)

Nureca Limited to Report Q1, 2023 Results on Aug 12, 2022

Nureca Limited Approves Director Appointments

Full year 2022 earnings released: EPS: ₹44.96 (vs ₹62.04 in FY 2021)

Nureca Limited, Annual General Meeting, Jul 21, 2022

Nureca Limited to Report Q4, 2022 Results on May 28, 2022

High number of new and inexperienced directors

Nureca Limited Announces Resignation of Sushil Kumar Bhardwaj as Director, with Effect from February 28, 2022

Upcoming dividend of ₹3.00 per share

Nureca Limited Appoints Sushil Kumar Bhardwaj as Additional Director & Whole-Time Director of the Company Designated as Director - Compliance

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Director of Compliance & Additional Director Santosh Srivastava has left the company

Investor sentiment improved over the past week

Non-Executive Director Rajinder Sharma has left the company

First quarter 2022 earnings released: EPS ₹36.20 (vs ₹3.40 in 1Q 2021)

Investor sentiment improved over the past week

Chief Financial Officer Sakshi Mittal has left the company

Chief Financial Officer Sakshi Mittal has left the company

Full year 2021 earnings released: EPS ₹62.04 (vs ₹9.14 in FY 2020)

Investor sentiment improved over the past week

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin